S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
FB   185.92 (-2.35%)
MSFT   138.05 (-1.17%)
AMZN   1,763.32 (-1.35%)
CGC   20.00 (-3.66%)
NVDA   190.73 (-1.83%)
MU   43.47 (-4.46%)
T   38.23 (+1.08%)
F   9.29 (+1.98%)
ACB   3.71 (-4.63%)
NFLX   275.30 (-6.15%)
BAC   30.45 (+0.63%)
GILD   64.23 (-1.53%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
FB   185.92 (-2.35%)
MSFT   138.05 (-1.17%)
AMZN   1,763.32 (-1.35%)
CGC   20.00 (-3.66%)
NVDA   190.73 (-1.83%)
MU   43.47 (-4.46%)
T   38.23 (+1.08%)
F   9.29 (+1.98%)
ACB   3.71 (-4.63%)
NFLX   275.30 (-6.15%)
BAC   30.45 (+0.63%)
GILD   64.23 (-1.53%)
Log in

THERAPIX BIOSCI/S Stock Price, News & Analysis (NASDAQ:TRPX)

$2.58
-0.01 (-0.39 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$2.55
Now: $2.58
$2.58
50-Day Range
$2.26
MA: $2.61
$3.00
52-Week Range
$2.04
Now: $2.58
$9.30
Volume210 shs
Average Volume57,170 shs
Market Capitalization$9.06 million
P/E RatioN/A
Dividend YieldN/A
Beta0.85
Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include THX-110 for the treatment of Tourette syndrome, Obstructive Sleep Apnea, and pain; THX-130 for the treatment of Mild Cognitive Impairment and Traumatic Brain Injury; THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain. Therapix Biosciences Ltd. has a product development agreement with Cure Pharmaceutical to develop cannabinoid-based product for sleep disorders. The company was formerly known as NasVax Ltd. and changed its name to Therapix Biosciences Ltd. in November 2013. Therapix Biosciences Ltd. was founded in 2004 and is headquartered in Givatayim, Israel.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TRPX
CUSIPN/A
Phone972-3616-7055

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.02 per share

Profitability

Miscellaneous

Employees9
Market Cap$9.06 million
Next Earnings Date12/2/2019 (Estimated)
OptionableNot Optionable

Receive TRPX News and Ratings via Email

Sign-up to receive the latest news and ratings for TRPX and its competitors with MarketBeat's FREE daily newsletter.


THERAPIX BIOSCI/S (NASDAQ:TRPX) Frequently Asked Questions

What is THERAPIX BIOSCI/S's stock symbol?

THERAPIX BIOSCI/S trades on the NASDAQ under the ticker symbol "TRPX."

How were THERAPIX BIOSCI/S's earnings last quarter?

THERAPIX BIOSCI/S (NASDAQ:TRPX) posted its quarterly earnings results on Monday, August, 20th. The company reported ($0.35) earnings per share for the quarter, topping analysts' consensus estimates of ($0.59) by $0.24. View THERAPIX BIOSCI/S's Earnings History.

When is THERAPIX BIOSCI/S's next earnings date?

THERAPIX BIOSCI/S is scheduled to release their next quarterly earnings announcement on Monday, December 2nd 2019. View Earnings Estimates for THERAPIX BIOSCI/S.

Has THERAPIX BIOSCI/S been receiving favorable news coverage?

Press coverage about TRPX stock has trended negative this week, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. THERAPIX BIOSCI/S earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for THERAPIX BIOSCI/S.

Who are some of THERAPIX BIOSCI/S's key competitors?

What other stocks do shareholders of THERAPIX BIOSCI/S own?

Who are THERAPIX BIOSCI/S's key executives?

THERAPIX BIOSCI/S's management team includes the folowing people:
  • Dr. Ascher Shmulewitz, Chairman & Interim CEO (Age 63)
  • Dr. Adi Zuloff-Shani, Chief Technology Officer (Age 51)
  • Mr. Oz Adler CPA, Chief Financial Officer (Age 32)

How do I buy shares of THERAPIX BIOSCI/S?

Shares of TRPX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is THERAPIX BIOSCI/S's stock price today?

One share of TRPX stock can currently be purchased for approximately $2.58.

How big of a company is THERAPIX BIOSCI/S?

THERAPIX BIOSCI/S has a market capitalization of $9.06 million. THERAPIX BIOSCI/S employs 9 workers across the globe.View Additional Information About THERAPIX BIOSCI/S.

What is THERAPIX BIOSCI/S's official website?

The official website for THERAPIX BIOSCI/S is http://therapixbio.com/.

How can I contact THERAPIX BIOSCI/S?

THERAPIX BIOSCI/S's mailing address is 4 Ariel Sharon Street HaShahar Tower 16th Floor, Givatayim L3, 5320047. The company can be reached via phone at 972-3616-7055 or via email at [email protected]


MarketBeat Community Rating for THERAPIX BIOSCI/S (NASDAQ TRPX)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  217 (Vote Outperform)
Underperform Votes:  203 (Vote Underperform)
Total Votes:  420
MarketBeat's community ratings are surveys of what our community members think about THERAPIX BIOSCI/S and other stocks. Vote "Outperform" if you believe TRPX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRPX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Featured Article: Blockchain

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel